FDA approves first-ever mRNA flu vaccine for millions of older Americans

A new mRNA flu vaccine showed a 27% reduction in flu cases in a clinical trial, but its path to FDA approval faced an early regulatory setback. A new mRNA flu vaccine showed a 27% reduction in flu cases in a clinical trial, but its path to FDA approval faced an early regulatory setback.